BioSpace News Archive

Rigel Pharmaceuticals, Inc. announced that it intends to offer and sell up to 15,000,000 shares of its common stock in an underwritten public offering.

Entrinsic Health Solutions, Inc. announced the publication of research showing that the beverage hydration index (BHI) value of enterade ORS - an all-natural, glucose-free amino acid beverage - was greater and outperformed water and a sports drink.

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, plans to release its first quarter 2018 results after the financial markets close on Thursday, April 26, 2018.

City of Hope’s annual Kids 4 Hope program, in partnership with Albertsons Companies Foundation, Vons Foundation and Pavilions Foundation, has raised over $1 million to support research and treatment for pediatric cancers.

Invacare Corporation announces that it will release its financial results for the first quarter ended March 31, 2018, after the market closes on Monday, May 7, 2018.

Zimmer Biomet Holdings, Inc. announced an agreement with Oregon Surgical Institute.

Pfenex Inc. and China NT Pharma Group Company Limited announced an agreement under which Pfenex granted NT Pharma non-exclusive development and exclusive commercialization rights to PF708, a teriparatide therapeutic equivalent candidate to Eli Lilly & Company’s Forteo®, in Mainland China, Hong Kong, Singapore, Malaysia and Thailand.

GlaxoSmithKline plc and Innoviva, Inc. announced the publication in the New England Journal of Medicine (NEJM) of the landmark IMPACT study, one of the biggest ever conducted in patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbation.

bluebird bio, Inc. announced interim data published in the New England Journal of Medicine (NEJM) from two separate two-year clinical studies investigating the potential for LentiGlobin™ gene therapy to eliminate or reduce chronic blood transfusions in patients with transfusion-dependent β-thalassemia (TDT).

On the eve of the anniversary of the US Deepwater Horizon disaster, polluted beaches, oily water, dead birds and marine life destruction caused by crude oil spills could be a thing of the past thanks to pioneering research led by Flinders University.